Figure 2.

EUS guided antegrade treatment vs Balloon enteroscopy ERCP for biliary disease in patients with Roux en Y gastrectomy. (A) Forest plot comparing technical success of EUS-AG vs BE-ERCP for biliary disease in Roux en Y gastrectomy. (B) Forest plot comparing overall adverse effects of EUS-AG vs BE-ERCP for biliary disease in Roux en Y gastrectomy. (C) Forest plot comparing clinical success of EUS-AG vs BE-ERCP for biliary disease in Roux en Y gastrectomy. (D) Forest plot comparing rate of pancreatitis of EUS-AG vs BE-ERCP for biliary disease in Roux en Y gastrectomy. (E) Forest plot comparing rate of perforation of EUS-AG vs BE-ERCP for biliary disease in Roux en Y gastrectomy. (F) Forest plot comparing rate of bile peritonitis of EUS-AG vs BE-ERCP for biliary disease in Roux en Y gastrectomy

EUS-AG, endoscopic ultrasound-guided antegrade; BE-ERCP, balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography; CI, confidence interval